Capricor Therapeutics
CAPR
CAPR
25 hedge funds and large institutions have $5.14M invested in Capricor Therapeutics in 2020 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
6% less call options, than puts
Call options by funds: $851K | Put options by funds: $910K
23% less capital invested
Capital invested by funds: $6.64M → $5.14M (-$1.5M)
Holders
25
Holding in Top 10
–
Calls
$851K
Puts
$910K
Top Buyers
| 1 | +$637K | |
| 2 | +$271K | |
| 3 | +$169K | |
| 4 |
Bank of New York Mellon
New York
|
+$98.8K |
| 5 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
+$54K |
Top Sellers
| 1 | -$351K | |
| 2 | -$85K | |
| 3 | -$68K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$49.9K |
| 5 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
-$35.8K |